Log in to save to my catalogue

Proteogenomic Evaluation of Cerebrospinal Fluid in Alzheimer's Disease

Proteogenomic Evaluation of Cerebrospinal Fluid in Alzheimer's Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716760

Proteogenomic Evaluation of Cerebrospinal Fluid in Alzheimer's Disease

About this item

Full title

Proteogenomic Evaluation of Cerebrospinal Fluid in Alzheimer's Disease

Publisher

Hoboken: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2024-12, Vol.20 (S2), p.n/a

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley and Sons Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background
Alzheimer's disease (AD) is a complex disorder with a strong genetic component, yet many genetic risk factors remain unknown. Integrating genome‐wide association studies (GWAS) and high‐throughput proteomic platforms is a useful strategy to evaluate protein quantitative trait loci (pQTLs) and to detect candidate genes and pathways inv...

Alternative Titles

Full title

Proteogenomic Evaluation of Cerebrospinal Fluid in Alzheimer's Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716760

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716760

Other Identifiers

ISSN

1552-5260

E-ISSN

1552-5279

DOI

10.1002/alz.086066

How to access this item